Using bioinformatic analysis, we discovered that kinesin family member 22 (KIF22) is highly expressed in pancreatic cancer and that upregulation of KIF22 is associated with a poor prognosis in pancreatic cancer patients. Here, KIF22 is linked to familial pancreatic carcinoma.